Rottinghaus Scott T. (CIK 1942407) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-10). Recent activity: Sell ENTA (1,467 shares), Buy ENTA (1,650 shares), Buy ENTA (5,225 shares), Sell ENTA (3,413 shares), Sell ENTA (798 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-10 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Medical Officer | Sell | 1,467 | $19,570 |
| 2026-02-13 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Medical Officer | Buy | 1,650 | $0 |
| 2026-02-13 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Medical Officer | Buy | 5,225 | $0 |
| 2026-02-13 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Medical Officer | Sell | 3,413 | $48,635 |
| 2025-12-05 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Medical Officer | Sell | 798 | $11,356 |
| 2025-08-08 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Medical Officer | Sell | 2,217 | $15,497 |
Source: SEC Form 4 filings · as of 2026-08-10